Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 4 1Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Recurrence 1Leukemia, Myeloid, Acute 1Carcinoma, Hepatocellular 1

Interventions

Cytarabine 19Cyclophosphamide 18venetoclax 15fludarabine phosphate 14Busulfan 14Cyclosporine 12Azacitidine 11fludarabine 10Peripheral Blood Stem Cell Transplantation 10Granulocyte Colony-Stimulating Factor 10Mycophenolic Acid 9Filgrastim 9Melphalan 8Antilymphocyte Serum 8Whole-Body Irradiation 7Palliative Care 7Idarubicin 6Blood Specimen Collection 6Methotrexate 5Therapeutics 4Specimen Handling 4Radiotherapy 4Methods 4Early Intervention, Educational 4Daunorubicin 4Cord Blood Stem Cell Transplantation 4thymoglobulin 3Thiotepa 3Tacrolimus 3Psychiatric Rehabilitation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Myeloid, Acute × Interferon-alpha × Clear all
NCT03121079 2020-09-23

Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation

Peking University People's Hospital

Phase NA Withdrawn
Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡